PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Insulin aspart→

Insulin Aspart PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
116094-23-6
PubChem CID
16132418
Molecular formula
C256H387N65O79S6
Molecular weight
5832 g/mol
Drug class
Insulin Analog
Mechanism of action
The primary activity of insulin, including NOVOLOG is the regulation of glucose metabolism.

Sources: FDA product labels (openFDA) · FDA product information

Identification source: PubChem record (CID 16132418). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Insulin Aspart PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Insulin Aspart Permitted Daily Exposure (PDE) report (the Insulin Aspart PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Insulin Aspart Occupational Exposure Limit (OEL) report (the Insulin Aspart OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.